MedTrace Logo

An Acute Human Intervention With Flavonoid to Investigate Absorption, Metabolism and Excretion

NCT01922869 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 240

Last updated 2013-08-14

No results posted yet for this study

Summary

The era of general dietary recommendations for the whole population may be coming to an end, as it is becoming apparent that we are all unique and do not respond in the same way to the same foods. Within a decade it is believed that doctors will be able to take profiles of their patients, identify specific diseases for which they are at risk and create personalised nutrition plans accordingly. At the University of East Anglia, UK the investigators are interested in particular food compounds known as flavonoids which can be found in foods such as chocolate, orange juice and blackberries (COB). The study will determine if factors such as age, gender, genetics and the bacteria present in our guts contribute to variability between individuals in their absorption, metabolism and excretion of flavonoids.

Conditions

  • Pharmacokinetics of Flavonoids in Humans

Interventions

DIETARY_SUPPLEMENT

Flavonoids

Sponsors & Collaborators

  • Fred Hutchinson Cancer Center

    collaborator OTHER

  • University of Washington

    collaborator OTHER

  • University of East Anglia

    lead OTHER

Principal Investigators

  • Anne-Marie Minihane, PhD · Department of Nutrition, University of East Anglia, Norwich, U.K.

Study Design

Allocation
NA
Purpose
BASIC_SCIENCE
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
77 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2013-07-31
Primary Completion
2014-05-31
Completion
2014-09-30

Countries

  • United Kingdom

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01922869 on ClinicalTrials.gov